Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients

View source ↗

Summary

A completed non-interventional study assessing Kyprolis in combination with Revlimid and dexamethasone, or dexamethasone alone, or with Darzalex and dexamethaso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DARZALEX (daratumumab)
  • DEXAMETHASONE (Dexamethasone)
  • Kyprolis (carfilzomib)
  • Revlimid (lenalidomide)

Snippet

Sponsor: iOMEDICO AG | Conditions: Multiple Myeloma in Relapse | Status: COMPLETED